Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy
Authors:
- Daniele BerraDBDaniele Berra
- Fabio L. RizziniFRFabio L. Rizzini
- Marina MauroMMMarina Mauro
- Antonietta MelchiorreAMAntonietta Melchiorre
- Francesco RossiFRFrancesco Rossi
- Daniele SpeziaDSDaniele Spezia
- Rosario StanizziRSRosario Stanizzi
- Luisa RicciardiLuisa Ricciardi
- Samuele E. BurasteroSBSamuele E. Burastero
- 1 July 2006
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 97 (1) , 92-97
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injectionsJournal of Allergy and Clinical Immunology, 2000
- Ultrarush SIT in venom allergyAllergy, 2000
- Epidemiology of hymenoptera allergyClinical & Experimental Allergy, 1994
- Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 yearsAllergy, 1993
- Immunotherapy with Yellow Jacket VenomAllergy, 1986
- Clustered Immunotherapy with Yellow Jacket VenomAllergy, 1985
- Immunotherapy in Bee Sting HypersensitivityAllergy, 1979
- A Controlled Trial of Immunotherapy in Insect HypersensitivityNew England Journal of Medicine, 1978
- A metabolizable adjuvant: clinical trial of grass pollen‐tyrosine adsorbateClinical & Experimental Allergy, 1974
- Experimental and clinical study of fresh and modified pollen extractsJournal of Allergy, 1940